News

Search:
 Search

Latest News | 17 May 2013

EMA Releases ICH Guideline on Manufacturing Impurities for Industry Consultation

0 Likes

The European Medicines Agency (EMA) has announced its adoption of the International Conference on Harmonisation's (ICH) M7 guideline on controlling carcinogenic risk in pharmaceutical products when Read More...


Latest News | 17 May 2013

Pharmaceutical Industry to FDA: Build Flexibility into GAIN Act

0 Likes

When legislators passed a sprawling piece of legislation known as the Food and Drug Administration Safety and Innovation Act (FDASIA), they considered a huge range of problems facing both the US Food Read More...


Latest News | 17 May 2013

FDA Data Show the Worst is Over for 510(k), PMA Submissions

0 Likes

The medical device industry has long complained that the process of obtaining regulatory approval for its devices has become increasingly difficult over the course of the last decade. But in a Read More...


Latest News | 17 May 2013

Regulatory Reconnaissance (17 May 2013)

0 Likes

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US Is the Hatch-Waxman Act Flawed and Should the Supreme Court Fix It? (Becker's Hospital Read More...


Latest News | 16 May 2013

Janssen's Simponi Wins New Indication for Treatment of Ulcerative Colitis

0 Likes

The US Food and Drug Administration (FDA) has announced the approval of additional indications for Simponi (golimumab), a drug manufactured by Janssen Biotech intended to treat adults with moderate to Read More...


Latest News | 16 May 2013

NIH Looks to Drug Reformulation, Social Media to Combat Opioid Abuse and Misuse

0 Likes

The US Food and Drug Administration (FDA) may be at the forefront of trying to prevent the misuse and abuse of opioid painkillers, but as two Federal Register notices this week point out, it's not the Read More...


Latest News | 16 May 2013

Is FDA Approving Too Many Drugs Starting with 'X' and 'Z'?

0 Likes

Regulators with the US Food and Drug Administration (FDA) had a few things to clarify with industry and medical practitioners in the latest issue of the New England Journal of Medicine.Namely: No, Read More...


Latest News | 16 May 2013

Adverse Event Database Identifies Two Drugs as Having Potential Safety, Efficacy Issues

0 Likes

A just-released update of the US Food and Drug Administration's Adverse Event Reporting System (FAERS) indicates that two drugs, metroprolol succinate extended release and serotonin-3 receptor Read More...


Latest News | 16 May 2013

Long-Awaited Guidance on CDRH's Appeals Process Released, Alleviating Some Industry Concerns

0 Likes

The US Food and Drug Administration (FDA) has released two long-awaited guidance documents regarding the appeals process to be used by medical device manufacturers that have received a rejection by Read More...


Latest News | 16 May 2013

Report Shows Big Increase in Pharmaceutical Recalls Led by Compounding Pharmacy Troubles

0 Likes

Recall reporting and consulting firm Stericycle is out with its latest quarterly report regarding the state of industry recalls, showing a disturbing trend in recalls led by compounding pharmacies and Read More...


1 2 3 4 5 6 7 8 9 10 ... 213
RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more


New Regulatory Focus Apps for iPad and iPhone